Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Large Decrease in Short Interest

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the recipient of a large drop in short interest during the month of December. As of December 31st, there was short interest totaling 8,630 shares, a drop of 75.5% from the December 15th total of 35,213 shares. Approximately 1.0% of the shares of the company are sold short. Based on an average daily trading volume, of 26,165 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily trading volume, of 26,165 shares, the days-to-cover ratio is presently 0.3 days. Approximately 1.0% of the shares of the company are sold short.

Virtus LifeSci Biotech Clinical Trials ETF Price Performance

Shares of BBC stock traded up $1.67 during trading hours on Wednesday, hitting $41.49. The stock had a trading volume of 14,205 shares, compared to its average volume of 36,578. The stock’s 50 day moving average is $37.18 and its 200 day moving average is $29.10. Virtus LifeSci Biotech Clinical Trials ETF has a twelve month low of $13.42 and a twelve month high of $41.49.

Virtus LifeSci Biotech Clinical Trials ETF Company Profile

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.